Treatment & symptomatic relief of erosive esophagitis in patients w/ GERD. Pathologic GI hypersecretory conditions associated w/ Zollinger-Ellison syndrome or other neoplastic conditions.
IV Administer at an infusion rate of 3 mg (7 mL)/min over approx 15 min. GERD 40 mg each day for 7-10 days. Pathologic GI hypersecretoryconditions 80 mg every 12 hr. Patients needing higher dose 80 mg every 8 hr.
Discontinue if anaphylaxis or other severe hypersensitivity reactions occur. Increased risk of developing infections eg, community-acquired pneumonia. Mild, transient elevation of serum ALT (SGPT). Pregnancy. Discontinue during lactation. Childn <18 yr.
A02BC02 - pantoprazole ; Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
Sign Out
